🟢 Arcturus Therapeutics is trading 6% up in pre-market with no clear catalyst identified

Arcturus Therapeutics is trading at $11.38, up 6.06%, with no clear company-specific announcement or catalyst identified for October 23, 2026.

• The stock is rising despite modestly lower U.S. index futures and elevated oil prices amid geopolitical tensions; this backdrop does not clearly explain the move.
• The September 23 company announcement about interim Phase 2 data and its LUNAR 2.0 platform is older news, not a confirmed new catalyst for this pre-market move.